drugset / Trial / NCT06193538
The Safety and Effectiveness of NV-A01 in Glioma Patients
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to learn about the safety and effectiveness of NV-A01 in the treatment of advanced glioma patients. The main questions it aims to answer are: 1. The safety of NV-A01 in the treatment of advanced glioblastoma patients. 2. The effectiveness of NV-A01 in treating patients with advanced glioblastoma.
Timeline
- Start
- 2023-09-14
- Primary completion
- 2024-12
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NV-A01 | Unknown | — | Other |